Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.41 |
| ▸ | CCR8 | P51685 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 2/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.36 |
| ▸ | GABRE | P78334 | 1/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.36 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22373875 | 0.88 | L3MBTL1 (0.41) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL13509561 | 0.78 | NPC1 (0.41) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL19039381 | 0.78 | UHRF1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL19978072 | 0.77 | GABRP (0.55) | NPC1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL24623618 | 0.77 | MEN1 (0.38) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL22373919 | 0.77 | ALDH1A1 (0.46) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL16919861 | 0.75 | ALDH1A1 (0.42) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL25461379 | 0.74 | GRM4 (0.44) | CCR1CCR8NPC1CYP1A2PDE4D | |
| SCHEMBL11884998 | 0.74 | TDO2 (0.42) | L3MBTL1NPC1HSP90AA1CYP2A6HTT | |
| SCHEMBL6925972 | 0.73 | KDM4E (0.48) | CCR1CCR8L3MBTL1NPC1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | CCR1 853/4885CCR8 1533/4885L3MBTL1 1754/4885 |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | CCR1 853/4885CCR8 1533/4885L3MBTL1 1754/4885 |
| US-11758807-B2 | Organic electroluminescent materials and devices | GLRA3, ESRRG, GLRA1 | CCR1 853/4885CCR8 1533/4885L3MBTL1 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.